Osteopore Ltd (ASX: OSX) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

Osteopore Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $2.60 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 173.43 million
Earnings per share -0.043
Dividend per share N/A
Year To Date Return -57.14%
Earnings Yield N/A
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

Osteopore Ltd (ASX: OSX)
Latest News

Three healthcare workers look and point at at medical image
Healthcare Shares

Osteopore (ASX:OSX) share price rockets 24% on major new deal

This healthcare company is having a good day on the ASX today

Read more »

asx medical share price represented by x-ray or people shaking hands
Share Market News

Osteopore (ASX:OSX) share price moving higher on distribution deal

The Osteopore share price has moved higher today on news of distribution deal. This will see its products promoted into Germany…

Read more »

soaring hydrix share price represented by doctor riding on top of heart high up in the clouds
Investing

Why I think these small cap ASX shares will perform in 2021

The ASX is littered with lots of companies that show potential to become the next market darling. Here are my…

Read more »

man using 3d printer
Share Market News

ASX medical share surges 30% on development news

This ASX medical share surged more than 30% after announcing an agreement with QUT on potentially revolutionary 3D technology.

Read more »

Share Market News

2 breakthrough ASX healthcare shares

Australia has helped shape modern medicine in many ways. These 2 ASX healthcare shares are breakthrough companies with strong momentum.

Read more »

Female Archer Materials staffer standing in front of computerised images
Investing

3 innovative ASX shares to buy

Here's a closer look at 3 innovative ASX shares to buy to capitalise on Australian innovation, including Electro Optic Systems…

Read more »

Rocket launching into space
Share Market News

Osteopore share price storms 270% higher on distribution deal

The Osteopore Ltd (ASX: OSX) share price was up more than 260% at one point today, after the company signed…

Read more »

OSX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Osteopore Ltd

Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

OSX Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
21 May 2025 $0.02 $0.00 0.00% 199,448 $0.01 $0.02 $0.01
20 May 2025 $0.02 $0.00 0.00% 20,324 $0.01 $0.02 $0.01
19 May 2025 $0.02 $0.00 0.00% 1,312,491 $0.01 $0.02 $0.01
16 May 2025 $0.01 $0.00 0.00% 649,828 $0.01 $0.01 $0.01
15 May 2025 $0.02 $0.00 0.00% 531,224 $0.01 $0.02 $0.01
14 May 2025 $0.01 $0.00 0.00% 3,412,926 $0.01 $0.02 $0.01
13 May 2025 $0.02 $0.00 0.00% 393,820 $0.02 $0.02 $0.02
12 May 2025 $0.02 $0.00 0.00% 1,540,298 $0.02 $0.02 $0.02
09 May 2025 $0.01 $0.00 0.00% 522,889 $0.02 $0.02 $0.01
08 May 2025 $0.01 $0.00 0.00% 1,816,379 $0.01 $0.01 $0.01
07 May 2025 $0.01 $0.00 0.00% 2,367,112 $0.02 $0.02 $0.01
06 May 2025 $0.02 $0.00 0.00% 7,841,031 $0.02 $0.02 $0.02
05 May 2025 $0.02 $0.00 0.00% 1,245,841 $0.02 $0.02 $0.02
02 May 2025 $0.02 $0.00 0.00% 1,015,613 $0.02 $0.02 $0.02
01 May 2025 $0.02 $0.00 0.00% 2,218,757 $0.02 $0.02 $0.02
30 Apr 2025 $0.02 $0.01 66.67% 4,540,326 $0.02 $0.02 $0.02
29 Apr 2025 $0.02 $0.00 0.00% 4,014,321 $0.02 $0.02 $0.02
28 Apr 2025 $0.02 $0.00 0.00% 6,504,654 $0.02 $0.02 $0.02
24 Apr 2025 $0.02 $0.00 0.00% 1,354,279 $0.02 $0.02 $0.02
23 Apr 2025 $0.02 $0.00 0.00% 778,930 $0.02 $0.02 $0.02

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
07 May 2025 Mark Leong Issued 5,625,000 $78,750
Issue of securities. 6,241,668 Performance rights
07 May 2025 Mark Leong Cancelled 616,668 $8,633
Cancellation of securities. 5,625,000 Performance rights
07 May 2025 Swee Hin Teoh Issued 625,000 $8,750
Issue of securities. 625,000 Rights
07 May 2025 Swee Hin Teoh Cancelled 61,668 $863
Cancellation of securities.
07 May 2025 Daniel Ow Issued 625,000 $8,750
Issue of securities. 625000 Rights
07 May 2025 Daniel Ow Cancelled 61,668 $863
Cancellation of securities.
07 May 2025 Michael Keenan Issued 625,000 $8,750
Issue of securities. 625,000 Rights
07 May 2025 Yujing Lim Issued 526,754 $7,374
Issue of securities.
07 May 2025 Yujing Lim Issued 4,125,000 $57,750
Issue of securities. 4,125,000 Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Mark Kei Wei Leong Executive ChairmanExecutive Director Aug 2021
Mr Leong has corporate, management and directorship experience in a broad range of functions in a diverse range of industries having undertaken several C-suite roles (CEO, COO, & CFO) in several private as well as listed companies.
Professor Swee Hin Teoh Non-Executive Director Jun 2019
Mr Teoh presently focuses on regenerative medicine research from tissue engineering bone and skin to biomimetic bioreactors to fish collagen, decellularized organs and others. He is a forerunner and educator in bioengineering and research scientist in translational regenerative medicine. His research focused on the study of mechanisms that promote cells proliferation and differentiation as a result of mechano-induction through load bearing scaffolds for tissue regeneration and
remodeling.
Mr Daniel Ow Non-Executive Director Oct 2021
Mr Ow has more than twenty years of international experience spanning various industries, such as infrastructure, resources, property, and fast-moving consumer goods. Throughout his career, he has undertaken several finance and management positions within prominent multinational corporations. Presently, Mr. Ow holds the role of Chief Financial Officer at Greenpool Capital, a fully integrated property investment, asset, and development firm. In addition to his professional endeavors, he has also served as a Trustee Director on the Rio Tinto Staff Superannuation Fund, which has since merged with Equip Super.
Hon Michael Keenan Non-Executive Director Jul 2023
Mr Keenan is a former Australian Government Cabinet Minister and brings expertise in public policy and corporate governance. He served as a Federal Member of Parliament from 2004 to 2019, holding senior ministry positions in the Abbott, Turnbull, and Morrison Governments between 2013 to 2019. His ministerial portfolios included Human Services, where he provided direction and oversight of Medicare, as well as Justice, Counterterrorism, and Digital Transformation. Notably, Mr. Keenan also serves on the Board of U Group and Co, as well as the Australian Strategic Policy Institute.
Dr Yujing Lim Chief Executive OfficerExecutive Director Jul 2023
No profile reported.
Mr Jack Rosagro Company Secretary May 2024
-
Jack Rosagro Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Citicorp Nominees Pty Limited 11,475,785 9.49%
BNP Paribas Nominees Pty Ltd <Uobkh R'Miers> 7,493,264 6.20%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 6,123,942 5.07%
Mr Kelvin Chua Yong Wei 3,480,919 2.88%
BNP Paribas Noms Pty Ltd 3,464,764 2.87%
Mr Evan Philip Clucas & Ms Leanne Jane Weston <Kuranga Nursery Super A/C> 3,273,864 2.71%
Mr Michael John Donnelly & Mrs Kylie Jayne Donnelly <M Donnelly Superfund A/C> 3,119,207 2.58%
Mr Rommel Ainza Gan & Ms Shennie Chua Chua 2,819,000 2.33%
Exosphere Investments Pty Ltd 2,619,067 2.17%
Dr Russell Kay Hancock 2,000,000 1.65%
Ms Fiona Elizabeth Greenhill 1,923,245 1.59%
ABN Amro Clearing Sydney Nominees Pty Ltd <Custodian A/C> 1,865,213 1.54%
Advance Opportunities Fund I 1,567,398 1.30%
Mr Andrew Fraser Kerr 1,540,000 1.27%
Terry Morris Pty Ltd <Morris Family Super A/C> 1,275,000 1.05%
Koroneos Holdings Pty Ltd 1,000,000 0.83%
Mr Mao Cai 907,440 0.75%
Merrill Lynch (Australia) Nominees Pty Limited 900,103 0.74%
Ms Kathleen Han 894,504 0.75%
Ms Fiona Elizabeth Greenhill i 835,767 0.69%

Profile

since

Note